Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
6x0UNEMaDyXRN4Cv
